Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENG Block vs L-ESPB + S-ESPB for Analgesia in THA
NCT07180979Phase 4Recruiting
- Sponsor
- Poznan University of Medical Sciences
- Start
- Sep 2025
- Primary completion
- Sep 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of ropivacaine in hip osteoarthritis, hip arthropathy, chronic hip pain, sponsored by Poznan University of Medical Sciences. Started Sep 2025; status: recruiting.
02
Drugs
ropivacaine
03
Conditions
hip osteoarthritiship arthropathychronic hip pain
Beyond the preview
Go deeper on NCT07180979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07180979.